Revascularization of both cardiac ventricles by right ventricular implants

Insights

Right internal mammary artery implantation into the right ventricle effectively relieved anginal pain and chronic left ventricular failure in 48 patients. This surgical procedure demonstrated significant long-term survival benefits for patients with prior myocardial infarctions.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Procedures
  • Myocardial Revascularization

Background:

  • Coronary artery disease remains a leading cause of mortality and morbidity.
  • Surgical revascularization techniques are crucial for managing refractory angina and heart failure.
  • Internal mammary artery grafts are known for their long-term patency rates.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of right internal mammary artery implantation into the right ventricle.
  • To assess the impact of this procedure on anginal pain and left ventricular failure.
  • To determine the long-term survival in patients undergoing this intervention, particularly those with prior myocardial infarctions.

Main Methods:

  • Retrospective analysis of 48 patients who underwent right internal mammary artery implantation into the right ventricle.
  • Follow-up duration exceeding six months for all patients.
  • Procedure performed either concurrently with or subsequent to left ventricular implantation.

Main Results:

  • Significant relief of anginal pain in 78% of patients.
  • Improvement in chronic left ventricular failure symptoms in 75% of patients.
  • Among 40 patients with pre-existing myocardial infarctions, 36 survived with an average follow-up exceeding 5 years.

Conclusions:

  • Right internal mammary artery implantation into the right ventricle is an effective surgical option for patients with refractory coronary artery disease.
  • The procedure offers substantial symptomatic relief and improves survival rates, especially in high-risk patient populations.
  • This technique represents a viable therapeutic strategy for managing severe ischemic heart conditions.